drugset / Trial / NCT06323928
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this trial is to determine which doses of Lu AG09222 are recommended to help prevent migraines. People who join this trial have already tried 1 to 4 other available medications to prevent their migraines, but these medications have not helped them.
Timeline
- Start
- 2024-04-01
- Primary completion
- 2026-01-16
- Completion
- 2026-03-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AG09222 | Monoclonal antibody | — | Subcutaneous |